The text discusses various studies on prognostic factors, biomarkers, and treatment options for non-metastatic colon cancer, including the impact of tumor deposits, adjuvant chemotherapy timing, CDX2 protein expression, molecular subtypes, PIK3CA mutation, and circulating tumor DNA.